Health-related quality of life in patients with cryptogenic polyneuropathy compared with the general population

Disability and Rehabilitation

Volumn 33, Issue 7, 2011, Pages 617-623

  Lindh, Jonas ^a   Tondel, Martin ^b   Persson, Bodil ^c   Vrethem, Magnus ^c  

^a RYHOV COUNTY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Activities of daily living; EuroQol; neurological disease; neuropathy; polyneuropathy

Indexed keywords

ADAPTATION; ADAPTIVE BEHAVIOR; ADULT; AGE; AGED; ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; DAILY LIFE ACTIVITY; DISEASE COURSE; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; NONPARAMETRIC TEST; PHYSIOTHERAPY; POLYNEUROPATHY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; REFERENCE VALUE; RISK ASSESSMENT; SEX DIFFERENCE; SWEDEN;

ACTIVITIES OF DAILY LIVING; ADAPTATION, PHYSIOLOGICAL; ADAPTATION, PSYCHOLOGICAL; ADULT; AGE FACTORS; AGED; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PHYSICAL THERAPY MODALITIES; POLYNEUROPATHIES; QUALITY OF LIFE; QUESTIONNAIRES; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STATISTICS, NONPARAMETRIC; SWEDEN;

EID: 79951912959     PISSN: 09638288     EISSN: 14645165     Source Type: Journal    
DOI: 10.3109/09638288.2010.505996     Document Type: Article

References (29)

1. MacDonald BK, Cockerell OC, Sander JW, Shorvon SD. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. [See comment]. Brain 2000;123(Part 4):665-676.
2. McLeod JG, Tuck RR, Pollard JD, Cameron J, Walsh JC. Chronic polyneuropathy of undetermined cause. J Neurol Neurosurg Psychiatry 1984;47:530-535.
3. Notermans NC, Wokke JH, Franssen H, van der Graaf Y, Vermeulen M, van den Berg LH, Bar PR, Jennekens FG. Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry 1993;56:1066-1071.
4. Mygland A, Monstad P. Chronic polyneuropathies in Vest-Agder, Norway. Eur J Neurol 2001;8:157-165.
5. Lindh J, Tondel M, Österberg A, Vrethem M. Cryptogenic polyneuropathy: clinical and neurophysiological findings. J Peripher Nerv Syst 2005;10:31-37. (Pubitemid 40289579)
6. Apostolou TG, Gokal R. Neuropathy and quality of life in diabetic continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1999;19(Suppl 2):S242-S247. (Pubitemid 30015485)
7. Currie CJ, Poole CD, Woehl A, Morgan CL, Cawley S, Rousculp MD, Covington MT, Peters JR. The financial costs of healthcare treatment for people with Type 1 or Type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy. Diabet Med 2007;24:187-194. (Pubitemid 46174943)
8. Hoffman DL, Sadosky A, Alvir J. Cross-national burden of painful diabetic peripheral neuropathy in Asia, Latin America, and the Middle East. Pain Pract 2009;9:35-42.
9. Jensen MP, Chodroff MJ, Dworkin RH. The impact of neuropathic pain on health-related quality of life: review and implications. Neurology 2007;68:1178-1182. (Pubitemid 46608464)
10. Padua L, Pazzaglia C, Cavallaro T, Commodari I, Pareyson D, Quattrone A, Rizzuto N, Vita G, Tonali PA, Schenone A. Quality of life is not impaired in patients with hereditary neuropathy with liability to pressure palsies. Eur J Neurol 2007;14:e45-e46. (Pubitemid 46088025)
11. Padua L, Cavallaro T, Pareyson D, Quattrone A, Vita G, Schenone A, the Italian CMTQSG. Charcot-Marie-Tooth and pain: correlations with neurophysiological, clinical, and disability findings. Neurol Sci 2008;29:193-194.
12. Cocito D, Paolasso I, Pazzaglia C, Tavella A, Poglio F, Ciaramitaro P, Scarmozzino A, Cossa F, Bergamasco B, Padua L. Pain affects the quality of life of neuropathic patients. Neurol Sci 2006;27:155-160. (Pubitemid 44161039)
13. Garssen MP, Bussmann JB, Schmitz PI, Zandbergen A, Welter TG, Merkies IS, Stam HJ, van Doorn PA. Physical training and fatigue, fitness, and quality of life in Guillain- Barre syndrome and CIDP. Neurology 2004;63:2393-2395. (Pubitemid 40024359)
14. Merkies IS, Schmitz PI, van der Meche FG, Samijn JP, van Doorn PA, Group INCaT. Quality of life complements traditional outcome measures in immune-mediated polyneuropathies. Neurology 2002;59:84-91.
15. Pfeiffer G, Wicklein EM, Ratusinski T, Schmitt L, Kunze K. Disability and quality of life in Charcot-Marie-Tooth disease type 1. J Neurol Neurosurg Psychiatry 2001;70:548-550. (Pubitemid 32269700)
16. Teunissen LL, Eurelings M, Notermans NC, Hop JW, van Gijn J. Quality of life in patients with axonal polyneuropathy. J Neurol 2000;247:195-199. (Pubitemid 30189401)
17. Vinci P, Serrao M, Millul A, Deidda A, De Santis F, Capici S, Martini D, Pierelli F, Santilli V. Quality of life in patients with Charcot-Marie-Tooth disease. [See comment]. Neurology 2005;65:922-924.
18. Liedberg GM, Vrethem M. Polyneuropathy, with and without neurogenic pain, and its impact on daily life activities - a descriptive study. Disabil Rehabil 2009:31:1-7.
19. Abresch RTC, JensenGT, KilmerMP,David D. Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease. AmJ Hosp Palliat Care 2002;19:39-48.
20. Erdmann P, Teunissen L, van Genderen F, Notermans N, Lindeman E, Helders P, van Meeteren N. Functioning of patients with chronic idiopathic axonal polyneuropathy (CIAP). J Neurol 2007:254:1204-1211.
21. Nordlund A, Ekberg K, Kristenson M. EQ-5D in a general population survey - a description of the most commonly reported EQ-5D health states using the SF-36. Qual Life Res 2005;14:1099-1109. (Pubitemid 40685232)
22. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
23. Sullivan M, Karlsson J. The Swedish SF-36 Health Survey III. Evaluation of criterion-based validity: results from normative population. J Clin Epidemiol 1998;51:1105-1113. (Pubitemid 28527166)
24. Sullivan M, Karlsson J, Ware JE Jr. Hälsoenkät: Svensk manual och tolkningsguide (Swedish Manual and Interpretation Guide). Gothenburg: Sahlgrenska University Hospital; 1994.
25. Brazier J, Jones N, Kind P. Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Qual Life Res 1993;2:169-180. (Pubitemid 23203441)
26. EuroQoul-Group. Electronic citation. 〈http://www.euroqol.org/ fileadmin/user-upload/Documenten/PDF/User-Guide-v2-March-2009.pdf〉. Last accessed 25 April 2009.
27. Rudolph T, Farbu E. Hospital-referred polyneuropathiescauses, prevalences, clinical- and neurophysiological findings. Eur J Neurol 2007;14:603-608. (Pubitemid 46849049)
28. Jann S, Sandro Beretta Manuela Bramerio Carlo Alberto Defanti. Prospective follow-up study of chronic polyneuropathy of undetermined cause. Muscle Nerve 2001;24:1197-1201.
29. Hughes RAC, Umapathi T, Gray IA, Gregson NA, Noori M, Pannala AS, Proteggente A, Swan AV. A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy. Brain 2004;127:1723-1730. (Pubitemid 39061549)